Literature DB >> 11040424

Complement activation in SCID and nude mice is related to severity of tissue inflammation in the Candida mastitis model.

F A Guhad1, H E Jensen, J Hau.   

Abstract

A small animal model of localised candidiasis is needed for the evaluation of new antifungal compounds. Mammary glands of immunocompetent (BALB/cJ) and immunodeficient (SCID and athymic nude) mice were infected with a wild-type of Candida albicans. Some of the animals were treated with amphotericin B (AmB) while others were treated with saline and acted as controls. The histologic changes of infected mammary gland tissues and a number of other organs were evaluated. Complement (C) activation was analysed by immunoelectrophoretic quantification of molecules with C3c epitopes (C3, C3b, iC3b, and C3c) in serum. In all animals the organisms were confined to the mammary glands. Serum C3c levels were significantly higher (P<0.05) in infected untreated BALB/cJ and SCID mice, which also had severe mammary gland tissue inflammation, compared with control mice treated with AmB (4 mg kg(-1) i.p. once daily for 4 days). Both treated and control nude mice showed less tissue inflammation compared to BALB/cJ and SCID mice, and revealed insignificant activation of the complement system. It is concluded that innate immune response is important in the control of candidiasis and that the murine mastitis model is useful for immunopathological studies as well as evaluation of potential antifungal compounds.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11040424     DOI: 10.1111/j.1574-6968.2000.tb09354.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  6 in total

1.  Anti-human CD99 antibody exerts potent antitumor effects in mantle cell lymphoma.

Authors:  Nuchjira Takheaw; Gunya Sittithumcharee; Ryusho Kariya; Watchara Kasinrerk; Seiji Okada
Journal:  Cancer Immunol Immunother       Date:  2020-11-19       Impact factor: 6.968

2.  Potent Therapeutic Activity Against Peritoneal Dissemination and Malignant Ascites by the Novel Anti-Folate Receptor Alpha Antibody KHK2805.

Authors:  Munetoshi Ando; Keiko Nagata; Kaito Nihira; Yui Suzuki; Yutaka Kanda; Maiko Adachi; Tsuguo Kubota; Naoya Kameyama; Mariko Nakano; Hiroshi Ando; Kazuya Yamano; Toshihiko Ishii; Ryuichiro Nakai; Kazuyasu Nakamura
Journal:  Transl Oncol       Date:  2017-07-12       Impact factor: 4.243

3.  Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts.

Authors:  Kristina A Butler; Xiaonan Hou; Marc A Becker; Valentina Zanfagnin; Sergio Enderica-Gonzalez; Daniel Visscher; Kimberly R Kalli; Piyawan Tienchaianada; Paul Haluska; S John Weroha
Journal:  Neoplasia       Date:  2017-06-26       Impact factor: 5.715

4.  Cow-to-mouse fecal transplantations suggest intestinal microbiome as one cause of mastitis.

Authors:  Chen Ma; Zheng Sun; Benhua Zeng; Shi Huang; Jie Zhao; Yong Zhang; Xiaoquan Su; Jian Xu; Hong Wei; Heping Zhang
Journal:  Microbiome       Date:  2018-11-08       Impact factor: 14.650

5.  Investigation of factors affecting the efficacy of 3C23K, a human monoclonal antibody targeting MISIIR.

Authors:  Sarah E Gill; Qing Zhang; Gary L Keeney; William A Cliby; S John Weroha
Journal:  Oncotarget       Date:  2017-07-27

Review 6.  The Role of T Lymphocytes in Cutaneous Scarring.

Authors:  Walker D Short; Xinyi Wang; Sundeep G Keswani
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-08-27       Impact factor: 4.730

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.